I've been reading about the connection between immunotherapy and cancer. Does this mean that if I use an immunotherapy drug for MS that it might lead to cancer, or would it help deter cancer?
Most of the therapies used in RRMS have not had any association with cancer, there are some exceptions. The most notable, is the recently approved ocrelizumab which has a listed concern for breast cancer based on the trials. This link was weak, but the FDA noted it on the drug’s label. There are no known benefits from MS therapies relative to cancer risk.
Benjamin M. Greenberg, MD, MHS
Vice Chair of Translational Research and Strategic Initiatives
Cain Denius Scholar of Mobility Disorders
Distinguished Teaching Professor
Department of Neurology and Neurotherapeutics
Department of Pediatrics
UT Southwestern Medical Center